UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005926
Receipt number R000007000
Scientific Title Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for taxane/platinum resistant ovarian, fallopian tube or primary peritoneal cancer
Date of disclosure of the study information 2011/07/05
Last modified on 2018/02/06 17:26:24

No. Disposal Last modified on Item of update
1 Insert 2011/07/05 18:19:46
2 Update 2011/07/05 21:17:22 Date of disclosure of the study information
3 Update 2011/07/05 21:22:12 Public title
4 Update 2011/07/08 19:44:07 Interventions/Control_1
Interventions/Control_1
5 Update 2014/07/07 14:48:54 Email
Email
6 Update 2017/07/09 09:07:29 Name of primary person or sponsor
Institute
Organization
Organization
7 Update 2017/07/09 09:11:09 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
8 Update 2017/07/09 09:12:37 Recruitment status
9 Update 2018/02/06 17:26:24 Publication of results
URL related to results and publications
Results